Are prognostic factors the key to precision medicine in CLL?
Advances in acute myeloid leukemia (AML) treatment – updating 7+3
Top follicular lymphoma discussion points at ICML 2017
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
The changing definition of complete remission in multiple myeloma
Carlos Fernandez de Larrea